What one share of Oramed Pharmaceuticals holds
We are a pharmaceutical company engaged in the research and development of innovative pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. In addition, we allocate capital to strategic investments in healthcare and life sciences companies that we believe complement our long-term business objectives and technology focus.
Oramed Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | $4.14 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.12 |
| Cash and investments | $0.92 |
| Book value | $7.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | $0.59 | $0.00 | −$0.47 | — | $1.02 |
| 2020 | $0.13 | $0.56 | $0.00 | −$0.61 | — | $1.39 |
| 2021 | $0.09 | $0.78 | $0.01 | −$0.76 | — | $3.28 |
| 2022 | $0.07 | −$0.94 | $0.01 | −$0.73 | — | $3.84 |
| 2023 | $0.03 | $0.14 | $0.01 | −$0.26 | — | $4.06 |
| 2024 | — | −$0.47 | $0.00 | −$0.21 | — | $3.66 |
| 2025 | $0.05 | $1.50 | $0.00 | −$0.22 | — | $5.09 |
Common questions about Oramed Pharmaceuticals
How much does one share of Oramed Pharmaceuticals earn?
Over the last 12 months, each share of Oramed Pharmaceuticals earned $4.14 of profit.
Does Oramed Pharmaceuticals pay a dividend?
Oramed Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Oramed Pharmaceuticals’s book value per share?
Oramed Pharmaceuticals’s book value is $7.68 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Oramed Pharmaceuticals have?
Each share of Oramed Pharmaceuticals has $0.92 of cash and investments, as of June 30, 2026.
What is Oramed Pharmaceuticals’s free cash flow per share?
−$0.12 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Oramed Pharmaceuticals’s profit per share changed over time?
Profit per share went from $0.59 in 2013 to $1.50 in 2025, growing about 8.1% a year (adjusted for stock splits).
Has Oramed Pharmaceuticals bought back shares?
Oramed Pharmaceuticals’s share count rose about 488% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.